Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-042376
Filing Date
2004-03-15
Accepted
2004-03-15 17:03:30
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 906699
3 CODE OF ETHICS dex14.htm EX-14 11140
4 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1805
5 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex232.htm EX-23.2 1661
6 CERTIFICATION BY CEO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex311.htm EX-31.1 7526
7 CERTIFICATION BY CFO PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT dex312.htm EX-31.2 7514
8 CERTIFICATION BY CEO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex321.htm EX-32.1 5350
9 CERTIFICATION BY CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT dex322.htm EX-32.2 5361
  Complete submission text file 0001193125-04-042376.txt   949588
Mailing Address 55 MADISON STREET SUITE 745 DENVER CO 80206
Business Address 55 MADISON STREET SUITE 745 DENVER CO 80206 3032932992
KFX INC (Filer) CIK: 0000912365 (see all company filings)

EIN.: 841079971 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-14176 | Film No.: 04670275
SIC: 2860 Industrial Organic Chemicals